Thrivent Financial for Lutherans
Position in BHC — Bausch Health Companies Inc.
CIK 314984
Minneapolis, MN
Position in BHC
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$676,834
+$101,168 QoQ
Shares Held
137,289
+28.8% QoQ
Ownership
0.037%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#76
of 220 holders
Holding Since
Mar 2020
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BHC Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Thrivent Financial for Lutherans holds $170,891,735 across 22 Drug Manufacturers - Specialty & Generic names. BHC ranks #18 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
128,626 | $69,693,424 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
297,297 | $50,106,435 | |
| 3 | ELAN |
Elanco Animal Health Inc
|
746,855 | $18,380,101 | |
| 4 | ALKS |
Alkermes plc.
|
109,450 | $5,735,180 | |
| 5 | LQDA |
Liquidia Corp
|
46,133 | $3,678,184 | |
| 6 | VTRS |
Viatris Inc
|
230,572 | $3,661,482 | |
| 7 | INDV |
Indivior Pharmaceuticals, Inc.
|
80,062 | $3,284,943 | |
| 8 | AMRX |
Amneal Pharmaceuticals, Inc.
|
113,125 | $1,958,193 |
All Filings in BHC
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $676,834 | 137,289 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $575,666 | 106,605 | Shares | Defined | 2026-05-01 | |
| 2023-06-30 | $505,448 | 63,181 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,489,613 | 183,903 | Shares | Defined | 2023-05-17 | |
| 2020-06-30 | $43,512,512 | 2,379,033 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $36,471,500 | 2,353,000 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||